Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Alert
Watchlist
Ind-Swift Ltd. - (Amalgamated)
₹15.70
0.00 (0.00%) 1D
Create Stock SIPAutomate your investments in this
Performance
Open
14.86Prev. Close
15.70Volume
0Total traded value
NAUpper Circuit
18.84Lower Circuit
12.56Fundamentals
| Market Cap | ₹85Cr |
| ROE | -1.94% |
| P/E Ratio(TTM) | 0.30 |
| EPS(TTM) | 52.33 |
| P/B Ratio | 0.00 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.86 |
| Book Value | -74.28 |
| Debt to Equity | -2.17 |
| Face Value | 2 |
Understand Fundamentals
Financials
About Ind Swift
Established in 1986, Ind-Swift is a research-driven pharmaceutical group from India, recognized for producing world-class finished dosage forms for various medical needs. The company's guiding principle is to serve humanity by offering quality medicines that help reduce illness and suffering, contributing to a better and healthier world. A key achievement is its significant export growth, with international sales now accounting for nearly 75.58% of its total revenue.;
| Parent Organisation | Ind Swift |
| Managing Director | Dr. Gopal Munjal |
| BSE Symbol | 524652 |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.60 | ||
| Gland Pharma | NA (0.00%) | 43.02 | ||
| Ajanta Pharma | NA (0.00%) | 32.53 | ||
| Eris Lifesciences | NA (0.00%) | 55.50 |